ValiRx PLC
02 May 2008

                                   ValiRx plc
                                (the "Company")


                           Result of General Meeting


The Company confirms that the following resolutions put to shareholders at
today's general meeting have been duly approved:



 1. an ordinary resolution to increase the authorised share capital of the
    company from £5,100,000 to £7,200,000;
 2. an ordinary resolution to authorise the Directors to allot relevant
    securities (as defined in section 80 of the Act) up to a maximum amount of
    £2,000,000; and
 3. a special resolution to allow the Directors, subject to the limits set out in
    that resolution, to issue shares for cash on a non-pre-emptive basis,
    including a specific authority to allot shares up to an aggregate nominal
    amount of £2,000,000.



Further to the announcment on 7 April 2008, application has been made for
7,473,332 new ordinary shares of 6p each in the Company ("Ordinary Shares"),
issued via a placing at 6p per share ("Placing Shares"), to be admitted to
trading on AIM and dealings are expected to commence on 6 May 2008 ("Admission
"). On Admission, the Company will have 41,603,095 Ordinary Shares in issue.



Attached to each Placing Share will be a warrant to subscribe for one new
Ordinary Share at 10p per share for a period of three years from the admission
of the Placing Shares to trading on AIM.





Contact Details:


         ValiRx Plc               WH Ireland Limited               GTH Communications
      Dr Satu Vainikka              David Youngman               Toby Hall / Brooke Paul
    +44 (0) 203 008 4416         +44 (0) 161 832 2174             +44 (0) 20 7153 8035








                      This information is provided by RNS
            The company news service from the London Stock Exchange

• News Channel